These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
160 related articles for article (PubMed ID: 11254546)
21. Toward primary prevention of asthma. Reviewing the evidence for early-life respiratory viral infections as modifiable risk factors to prevent childhood asthma. Feldman AS; He Y; Moore ML; Hershenson MB; Hartert TV Am J Respir Crit Care Med; 2015 Jan; 191(1):34-44. PubMed ID: 25369458 [TBL] [Abstract][Full Text] [Related]
23. Respiratory syncytial virus: different criteria for palivizumab use in different areas? Mitchell I South Med J; 2007 Jul; 100(7):661-2. PubMed ID: 17639741 [No Abstract] [Full Text] [Related]
25. Synagis now registered for the prevention of RSV disease in children with CHD. Cardiovasc J S Afr; 2006; 17(4):220. PubMed ID: 17001434 [No Abstract] [Full Text] [Related]
26. Revised indications for the use of palivizumab and respiratory syncytial virus immune globulin intravenous for the prevention of respiratory syncytial virus infections. American Academy of Pediatrics Committee on Infectious Diseases and Committee on Fetus and Newborn Pediatrics; 2003 Dec; 112(6 Pt 1):1442-6. PubMed ID: 14654627 [TBL] [Abstract][Full Text] [Related]
28. Respiratory syncytial virus lower respiratory tract infection in a pediatric liver transplant recipient treated with oral ribavirin. Keck M; Mindru C; Kalil AC; Mercer DF; Florescu DF Pediatr Transplant; 2012 Dec; 16(8):E348-51. PubMed ID: 22533837 [TBL] [Abstract][Full Text] [Related]
29. A review of respiratory syncytial virus infection in infants and children. Choy G Home Care Provid; 1998 Dec; 3(6):306-11. PubMed ID: 10030209 [TBL] [Abstract][Full Text] [Related]
30. Cost-effectiveness of palivizumab for respiratory syncytial virus infection in high-risk children, based on long-term epidemiologic data from Austria. Resch B; Sommer C; Nuijten MJ; Seidinger S; Walter E; Schoellbauer V; Mueller WD Pediatr Infect Dis J; 2012 Jan; 31(1):e1-8. PubMed ID: 21960187 [TBL] [Abstract][Full Text] [Related]
31. Prevention of respiratory syncytial virus infection in high risk infants. Prince AM; Jacobs RF J Ark Med Soc; 2001 Oct; 98(4):115-8. PubMed ID: 11594047 [TBL] [Abstract][Full Text] [Related]
33. Respiratory syncytial virus bronchiolitis in children. Verger JT; Verger EE Crit Care Nurs Clin North Am; 2012 Dec; 24(4):555-72. PubMed ID: 23089660 [TBL] [Abstract][Full Text] [Related]
34. Humanized monoclonal antibody for prevention of respiratory syncytial virus infection. Storch GA Pediatrics; 1998 Sep; 102(3 Pt 1):648-51. PubMed ID: 9738192 [No Abstract] [Full Text] [Related]
35. Abbott launches special programme for babies at high risk for respiratory syncytial virus. Cardiovasc J S Afr; 2007; 18(1):54. PubMed ID: 17393002 [No Abstract] [Full Text] [Related]
36. Treatment of bronchiolitis in infants. Panitch HB Pediatr Case Rev; 2003 Jan; 3(1):3-19. PubMed ID: 16222134 [No Abstract] [Full Text] [Related]
37. Respiratory tract infections caused by respiratory syncytial virus in children. Diagnosis and treatment. Van Woensel JB; Kimpen JL; Brand PL Minerva Pediatr; 2001 Apr; 53(2):99-106. PubMed ID: 11404731 [TBL] [Abstract][Full Text] [Related]
38. Respiratory syncytial virus and parainfluenza virus. Hall CB N Engl J Med; 2001 Jun; 344(25):1917-28. PubMed ID: 11419430 [No Abstract] [Full Text] [Related]
39. [Current news about epidemiology of syncytial respiratory virus infection]. Palumbo E Recenti Prog Med; 2008 May; 99(5):237-9. PubMed ID: 18581965 [TBL] [Abstract][Full Text] [Related]
40. Decline in respiratory syncytial virus hospitalizations in a region with high hospitalization rates and prolonged season. Singleton RJ; Bruden D; Bulkow LR; Varney G; Butler JC Pediatr Infect Dis J; 2006 Dec; 25(12):1116-22. PubMed ID: 17133156 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]